Details for New Drug Application (NDA): 202687
✉ Email this page to a colleague
NDA 202687 describes METHOXSALEN, which is a drug marketed by Actavis Inc, Ani Pharms, and Strides Pharma, and is included in three NDAs. It is available from one supplier. Additional details are available on the METHOXSALEN profile page.
The generic ingredient in METHOXSALEN is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
The generic ingredient in METHOXSALEN is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
Summary for 202687
| Tradename: | METHOXSALEN |
| Applicant: | Strides Pharma |
| Ingredient: | methoxsalen |
| Patents: | 0 |
Pharmacology for NDA: 202687
| Mechanism of Action | Photoabsorption |
| Physiological Effect | Photosensitizing Activity |
Medical Subject Heading (MeSH) Categories for 202687
Suppliers and Packaging for NDA: 202687
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| METHOXSALEN | methoxsalen | CAPSULE;ORAL | 202687 | ANDA | Strides Pharma Science Limited | 64380-752 | 64380-752-16 | 50 CAPSULE, LIQUID FILLED in 1 BOTTLE, GLASS (64380-752-16) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jun 5, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
